Log in


CINP2024 Confirmed Plenary Speakers

  • DR. VIRGINIA MAN-YEE LEEProfessor in Alzheimer's Research, University of Pennsylvania Perelman School of Medicine; Director, Center for Neurodegenerative Disease Research & Co-Director, Marian S. Ware Center for Alzheimer's Drug Discovery Program
  • DR. JOSHUA A. GORDONDirector of the National Institute of Mental Health (NIMH)
  • PROF. BELINDA LENNOXHead of Department of Psychiatry, University of Oxford & Honorary Consultant Psychiatrist in the Early Intervention in Psychosis service, Oxford Health NHS FT
  • DR. GEORGE F. KOOBDirector of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) 
  • DR. HARUO NAITO, Representative Corporate Officer and CEO of Eisai Co., Ltd.

President's Message

Following the resounding scientific and social success of CINP2023 in Montreal, preparations are now in full swing for next year’s meeting in Tokyo, Japan.

Important dates


Read the treatment guidelines on Schizophrenia & Bipolar written by CINP Members.

International Journal of Neuropsychopharmacology

Impact Factor: 5.678

CINP Leader Panel

International Panelists:
• Siegfried Kasper, Medical University of Vienna, Austria
• Gabriella Gobbi, McGill University, Canada
• John Krystal, Yale University School of Medicine, USA

©2021 CINP